This study was aimed to evaluate the post-infection cognitive functions of adult individuals with COVID-19. 50 individuals with COVID-19 and 50 healthy control groups were included in the study. Cognitive functions of individuals with COVID19 compared with healthy individuals.
This study was aimed to evaluate the post-infection cognitive functions of adult individuals
with COVID-19. Fifty COVID-19 patients, aged between 18-50 years, who had positive RT-PCR
test in the last 60 days and later recovered, were included in the study. The study group was
compared with the control group consisting of 50 healthy individuals in whom gender, age and
education year has not difference significantly. Participants' global cognitive skills were
measured by the Montreal Cognitive Assessment Test (MoCA), the Clock Drawing Test and memory
functions, the Öktem Verbal Memory Processes Test (Ö-SBST), the attention functions by the
Digit Span Forward and Digit Span Backwards Test, the executive functions by Categorical
Fluency, Phonemic Fluency, the Stroop Test, Trail Making Test A and B, visuospatial skills
were evaluated with the Rey-Osterrieth Complex Figure Test (ROCF), and behavioral symptoms
were evaluated with the Neuropsychiatric Inventory (NPI). The study group was evaluated
between 21 and 60 days from the onset of the disease.
Behavioral: Neuropsychometric Test
Participants' global cognitive skills were measured by the Montreal Cognitive Assessment Test (MoCA), the Clock Drawing Test and memory functions, the Öktem Verbal Memory Processes Test (Ö-SBST), the attention functions by the Digit Span Forward and Digit Span Backwards Test, the executive functions by Categorical Fluency, Phonemic Fluency, the Stroop Test, Trail Making Test A and B, visuospatial skills were evaluated with the Rey-Osterrieth Complex Figure Test (ROCF), and behavioral symptoms were evaluated with the Neuropsychiatric Inventory (NPI).
Other Name: Array
Inclusion Criteria:
- Having positive for the COVID-19 RT-PCR test and turned negative in the last 60 days.
- be 18-50 years old
- 21 days have passed since the onset of the disease
Exclusion Criteria:
- Having any neurological or psychiatric illness
Istanbul Medipol University
Beykoz, İstanbul, Turkey
Büşra Tüfekçi, MD, Principal Investigator
Medipol University